BindingDB logo
myBDB logout

18 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27810440 30 Synthesis and structure activity relationships of glycine amide derivatives as novel Vascular Adhesion Protein-1 inhibitors.EBI Astellas Pharma
24996144 20 Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents.EBI Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
23664164 40 Novel 1H-imidazol-2-amine derivatives as potent and orally active vascular adhesion protein-1 (VAP-1) inhibitors for diabetic macular edema treatment.EBI Astellas Pharma
23540955 24 Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2.EBI Astellas Pharma
23337801 24 Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema.EBI Astellas Pharma
20690686 52 Synthesis, in vitro activity, and three-dimensional quantitative structure-activity relationship of novel hydrazine inhibitors of human vascular adhesion protein-1.EBI Fi-40014 University Of Jyvaskyla
22595173 68 The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).EBI Pharmaxis
15689151 112 Alkylamino derivatives of 4-aminomethylpyridine as inhibitors of copper-containing amine oxidases.EBI Universit£
21405023 8 Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitors.EBI University Of Jyva£Skyla£
28245905 70 Synthesis of readily available fluorophenylalanine derivatives and investigation of their biological activity.BDB Charles University
27881238 6 Rational identification of natural organic compounds to target the intermolecular interaction between Foxm and DNA in colorectal cancer.BDB Linyi People'S Hospital
18578471 16 Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors.BDB Astrazeneca
16190759 60 A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and congeners.BDB Pfizer
28836754 31 Cell Lysate-Based AlphaLISA Deubiquitinase Assay Platform for Identification of Small Molecule Inhibitors.BDB University Of Delaware